Sri Krishna Pharmaceuticals is a Pharmaceutical company, CMO/CDMO company operating in the pharmaceutical industry.
Sri Krishna Pharmaceuticals Ltd (SKPL), established in 1974, started life as a pioneer in the bulk manufacture of acetaminophen (Paracetamol) for the domestic Indian market. Today, the company is a vertically integrated bulk manufacturer of multiple first-line-of-defence APIs, PFIs and finished dosage drugs. Paracetamol is still very important to the company and the company remains one of the largest manufacturers in the world.
Company type
Pharmaceutical company, CMO/CDMO
Products and services
Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Sri Krishna Pharmaceuticals on LinkedIn
Address
Sri Krishna Pharmaceuticals, C-4, IDA, Uppal, Hyderabad, Telangana, India, 500 039